Incyte Corporation (INCY)

Exchange
NASDAQ
Symbol
INCY
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    66.89
  • High
    69.11
  • Low
    66.89
  • Close
    68.84
  • Volume
    6,805,480

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
4.05
Receivables turnover
—
Payables turnover
2.33
Working capital turnover
1.08
Days of inventory on hand (DOH)
90.14
Days of sales outstanding (DSO)
—
Number of days of payables
156.89
Fixed asset turnover
4.91
Total asset turnover
0.54
 Liquidity ratios
Current ratio
3.75
Quick ratio
2.95
Cash ratio
2.95
Cash conversion cycle
-66.75
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.31
Interest coverage
328.01
 Profitability ratios
Gross profit margin
93.10%
Operating profit margin
16.80%
Pretax margin
22.59%
Net profit margin
16.18%
Operating return on assets (Operating ROA)
9.15%
Return on assets (ROA)
8.81%
Return on total capital
16.12%
Return on equity (ROE)
11.51%